MK0462 in Treatment of Migraine With Recurrence (MK0462-022)

PHASE3CompletedINTERVENTIONAL

Enrollment

1,473

Participants

Timeline

Start Date

March 31, 1995

Primary Completion Date

January 31, 1996

Study Completion Date

July 31, 1996

Conditions

Migraine Headache

Interventions

DRUG

rizatriptan benzoate (MK0462)

Single dose administration of 5 or 10 mg oral tablet of rizatriptan, taken immediately upon development of acute/severe migraine headache.

DRUG

Comparator: placebo

Placebo to rizatriptan

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00897949 - MK0462 in Treatment of Migraine With Recurrence (MK0462-022) | Biotech Hunter | Biotech Hunter